ADARx Pharmaceuticals, Inc. Common Stock (ADRX) News

Latest headlines that mention ADRX, newest first · each headline opens the original publisher

ADRX quote

Last price: $17.68
Day change: +1.99%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

ADRX headlines

last 30 days

Seeking Alpha 13d ago

ADARx Pharmaceuticals surges following upsized IPO

IPO T2ADRX

Investing.com 13d ago

Adarx Pharmaceuticals allocates 55% of IPO to 10 investors

IPO T3ADRX

Bloomberg Markets 14d ago

Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO

Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.

IPO T1ADRX

Investing.com 14d ago

ADARx Pharmaceuticals prices upsized IPO at $17 per share

IPO T3ADRX

Reuters 17d ago

Drug developer ADARx seeks $1.74 billion valuation in US IPO

IPO T1ADRX

Seeking Alpha News 28d ago

ADARx Pharmaceuticals Seeks IPO On Strong Collaboration Deal With AbbVie

IPO T2ABBV ADRX

Also mentioned with ADRX

30d

ABBV1

Headlines that tag both tickers

ADRX news alerts

Get an alert by email or push when a new headline mentions ADRX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.